lithium-investing Atlas Lithium Advances Neves Project with Final Stage of Project Management and Construction Supervision Contracting
lithium-investing Atlas Lithium Announces Pricing of $10 Million Registered Direct Offering with New U.S. Fundamental Institutional Investors
lithium-investing Atlas Lithium Reports Strong Financial Position and Advancement Towards Project Implementation
lithium-investing Atlas Lithium Corp Announced as Co-Host of the Brazil Critical Minerals Summit 2026
lithium-investing Atlas Lithium's Subsidiary Reports Outstanding Rare Earth Mineralization Across Two Project Types
lithium-investing Atlas Lithium's Critical Minerals Subsidiary Delivers Exceptional Rare Earths Grades and Premium Graphite Concentrate in Initial Reporting
FDA Accepts LEQEMBI® IQLIK Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
FDA Accepts LEQEMBI® IQLIKTM Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
CORRECTION - Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound
